SANDOZ TERIFLUNOMIDE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 446f8ab3ef1656dc
Drug Approval Canada Name: SANDOZ TERIFLUNOMIDE
Product Name: SANDOZ TERIFLUNOMIDE
Status: Marketed
Status Date: 2022-05-16
Original Market Date: 2022-05-16
Din: 02505843
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.20
Atc Original: L04AK02 TERIFLUNOMIDE
Atc Name: l 04 ak 02
Aig Number: 0154970001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

TERIFLUNOMIDE

14 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

446f8ab3ef1656dc

Type

Standard